JPRN-C000000292已完成未知
Control Group and Maintenance Treatment with Bacillus Calmette-Guerin for Superficial Bladder Cancer: A Prospective Randomized Trial - Bacillus Calmette-Guerin for Superficial Bladder Cancer
Oita BCG study group0 个研究点目标入组 110 人开始时间: 2005年12月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 110
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 79years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) invasive bladder cancer or history of invasive bladder cancer 2) malignant tumor in upper urinary tract or malignant tumor in urethra 3) lymph node or distant metastasis 4) injection of anticancer drug for bladder cancer. radiation for bladder cancer 5) immunosupressive glucocorticoid or other immunosupressive treatments 6) immunosupressive diseases 7) active malignant diseases except for bladder cancer 8) active tuberculosis or anti tuberculosis therapy 9) severe bacterial urinary tract infection disease or medical history of severe infection within 4 weeks 10) medical history of severe irritation or severe complications such as cardiovascular disorder, respiratory disease, kidney disease, liver disease or blood disease 11) medical history of BCG allergy 12) contracted bladder 13) interstitial pneumonia or pulmonary fibrosis 14) pregnant woman, nursing mother, woman expecting pregnancy 15) other concerns about BCG therapy (physician's decision)
研究者
相似试验
已完成
不适用
Maintenance therapy with bacillus Calmette-Guérin Connaught stain for non-muscle invasive bladder cancer after transurethral resection: prospective study with low-dose instillation.on muscle-invasive bladder cancerJPRN-UMIN000006362Graguate school of Medicine, Yamaguchi University30
已完成
不适用
Examination of combination and maintenance therapy with Adapalene Gel 0.1% for acne vulgarisJPRN-UMIN000004442Tokyo Woman's Medical University350
尚未招募
1 期
A study in blood cancer patients to check the effect of two oral drugs in maintaining the status of the patient disease free. The medicines that will be given are azacytidine and pomalidomide.CTRI/2023/09/057552Tata Memorial Centre
进行中（未招募）
不适用
未命名试验Advanced or metastatic predominantly transitional cell carcinoma of the urothelial tract.MedDRA version: 16.1Level: LLTClassification code 10046722Term: Urothelial carcinoma bladder stage IVSystem Organ Class: 100000004864EUCTR2011-000272-34-DEPIERRE FABRE MEDICAMENT77
进行中（未招募）
不适用
Study to assess the maintenance treatment with Vinflunine after a therapy with gemcitabine and cisplatin in patients with metastatic transitional cell carcinoma of the urothelial tract.EUCTR2011-000272-34-ITPIERRE FABRE MEDICAMENT77